Autism Research and Treatment / 2012 / Article / Fig 1

Research Article

Safety and Observations in a Pilot Study of Lenalidomide for Treatment in Autism

Figure 1

Concentration of 2.5 mgs lenalidomide up to eight hours after administration of first dose.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.